Wells Fargo & Company »

Compass Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $86k 47k 1.84
2024-06-30 $45k 45k 1.00
2024-03-31 $63k 32k 1.98
2023-12-31 $43k 28k 1.56
2023-09-30 $44k 22k 1.97
2023-06-30 $112k 35k 3.18
2022-12-31 $3.2k 636 5.03
2022-09-30 $1.0k 457 2.19